Joint (NASDAQ:JYNT) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Joint (NASDAQ:JYNT – Get Rating) in a report issued on Thursday morning. The firm issued a hold rating on the stock.

A number of other research firms also recently weighed in on JYNT. DA Davidson upgraded shares of Joint from an underperform rating to a neutral rating and lifted their price target for the stock from $12.00 to $15.00 in a research note on Monday, March 13th. B. Riley boosted their target price on shares of Joint from $23.00 to $26.00 in a research note on Friday, March 10th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of Hold and a consensus target price of $32.83.

Joint Stock Performance

JYNT traded down $0.07 during trading on Thursday, reaching $16.02. 135,641 shares of the company’s stock were exchanged, compared to its average volume of 123,072. Joint has a fifty-two week low of $12.85 and a fifty-two week high of $40.22. The company has a quick ratio of 0.87, a current ratio of 0.76 and a debt-to-equity ratio of 0.06. The business has a 50 day moving average price of $16.80 and a 200 day moving average price of $16.11. The company has a market capitalization of $232.77 million, a P/E ratio of 200.25 and a beta of 1.35.

Insider Activity

In other news, major shareholder Bandera Partners Llc bought 40,339 shares of Joint stock in a transaction dated Tuesday, January 3rd. The shares were bought at an average price of $13.45 per share, for a total transaction of $542,559.55. Following the purchase, the insider now owns 2,570,087 shares of the company’s stock, valued at $34,567,670.15. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Quadrature Capital Ltd bought a new position in shares of Joint in the third quarter valued at about $563,000. Divisadero Street Capital Management LP bought a new position in shares of Joint in the second quarter valued at about $306,000. Avondale Wealth Management raised its holdings in Joint by 700.0% during the 3rd quarter. Avondale Wealth Management now owns 6,000 shares of the company’s stock worth $94,000 after purchasing an additional 5,250 shares during the last quarter. Boston Partners raised its holdings in Joint by 63.8% during the 3rd quarter. Boston Partners now owns 31,184 shares of the company’s stock worth $490,000 after purchasing an additional 12,144 shares during the last quarter. Finally, Alta Fox Capital Management LLC raised its holdings in Joint by 11.5% during the 2nd quarter. Alta Fox Capital Management LLC now owns 111,500 shares of the company’s stock worth $1,707,000 after purchasing an additional 11,500 shares during the last quarter. 88.13% of the stock is owned by institutional investors.

About Joint

(Get Rating)

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit.